Literature DB >> 34608264

Decoupling tumor cell metastasis from growth by cellular pilot protein TNFAIP8.

Mingyue Li1, Xinyuan Li2, Jason R Goldsmith2, Songlin Shi2, Li Zhang2,3, Ali Zamani2, Lin Wan2, Honghong Sun2, Ting Li2, Jiyeon Yu2, Zienab Etwebi2, Mayassa J Bou-Dargham2, Youhai H Chen4,5.   

Abstract

Cancer metastasis accounts for nearly 90% of all cancer deaths. Metastatic cancer progression requires both cancer cell migration to the site of the metastasis and subsequent proliferation after colonization. However, it has long been recognized that cancer cell migration and proliferation can be uncoupled; but the mechanism underlying this paradox is not well understood. Here we report that TNFAIP8 (tumor necrosis factor-α-induced protein 8), a "professional" transfer protein of phosphoinositide second messengers, promotes cancer cell migration or metastasis but inhibits its proliferation or cancer growth. TNFAIP8-deficient mice developed larger tumors, but TNFAIP8-deficient tumor cells completely lost their ability to migrate toward chemoattractants and were defective in colonizing lung tissues as compared to wild-type counterparts. Mechanistically, TNFAIP8 served as a cellular "pilot" of tumor cell migration by locally amplifying PI3K-AKT and Rac signals on the cell membrane facing chemoattractant; at the same time, TNFAIP8 also acted as a global inhibitor of tumor cell growth and proliferation by regulating Hippo signaling pathway. These findings help explain the migration-proliferation paradox of cancer cells that characterizes many cancers.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34608264      PMCID: PMC8604770          DOI: 10.1038/s41388-021-02035-6

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  42 in total

1.  IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

Authors:  Shin Maeda; Hideaki Kamata; Jun-Li Luo; Hyam Leffert; Michael Karin
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

2.  Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non-Small Cell Lung Cancer Cells.

Authors:  Timothy F Day; Bhaskar V S Kallakury; Jeffrey S Ross; Olga Voronel; Shantashri Vaidya; Christine E Sheehan; Usha N Kasid
Journal:  Mol Cancer Res       Date:  2019-01-15       Impact factor: 5.852

3.  Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis.

Authors:  Toshiharu Sakurai; Guobin He; Atsushi Matsuzawa; Guann-Yi Yu; Shin Maeda; Gary Hardiman; Michael Karin
Journal:  Cancer Cell       Date:  2008-08-12       Impact factor: 31.743

4.  Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis.

Authors:  Jeremy B Swann; Matthew D Vesely; Anabel Silva; Janelle Sharkey; Shizuo Akira; Robert D Schreiber; Mark J Smyth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-04       Impact factor: 11.205

5.  Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.

Authors:  Fa-Xing Yu; Bin Zhao; Nattapon Panupinthu; Jenna L Jewell; Ian Lian; Lloyd H Wang; Jiagang Zhao; Haixin Yuan; Karen Tumaneng; Hairi Li; Xiang-Dong Fu; Gordon B Mills; Kun-Liang Guan
Journal:  Cell       Date:  2012-08-02       Impact factor: 41.582

6.  TIPE2 protein serves as a negative regulator of phagocytosis and oxidative burst during infection.

Authors:  Zhaojun Wang; Svetlana Fayngerts; Peng Wang; Honghong Sun; Derek S Johnson; Qingguo Ruan; Wei Guo; Youhai H Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

7.  c-Rel Is a Myeloid Checkpoint for Cancer Immunotherapy.

Authors:  Ting Li; Xinyuan Li; Ali Zamani; Wei Wang; Chin-Nien Lee; Mingyue Li; George Luo; Emily Eiler; Honghong Sun; Sankar Ghosh; Jian Jin; Ramachandran Murali; Qingguo Ruan; Weiyun Shi; Youhai H Chen
Journal:  Nat Cancer       Date:  2020-05-18

8.  TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.

Authors:  Ying Xing; Yuechao Liu; Tianbo Liu; Qingwei Meng; Hailing Lu; Wei Liu; Jing Hu; Chunhong Li; Mengru Cao; Shi Yan; Jian Huang; Ting Wang; Li Cai
Journal:  Cell Commun Signal       Date:  2018-07-31       Impact factor: 5.712

9.  TNFAIP8 promotes cell growth by regulating the Hippo pathway in epithelial ovarian cancer.

Authors:  Yao Xie; Fei Zhou; Xia Zhao
Journal:  Exp Ther Med       Date:  2018-10-02       Impact factor: 2.447

10.  GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis.

Authors:  Zefang Tang; Boxi Kang; Chenwei Li; Tianxiang Chen; Zemin Zhang
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

View more
  1 in total

Review 1.  Susceptibility of TNFAIP8, TNFAIP8L1, and TNFAIP2 Gene Polymorphisms on Cancer Risk: A Comprehensive Review and Meta-Analysis of Case-Control Studies.

Authors:  Khokon Kanti Bhowmik; Md Abdul Barek; Md Abdul Aziz; Mohammad Safiqul Islam
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.